Skip to main content
. 2022 May 12;5(5):e229655. doi: 10.1001/jamanetworkopen.2022.9655

Table 3. Concordance Results From the Analyses Across All Categories, Best Response, and in the Dichotomized Response/Nonresponse Categories.

Variable CAR [n = 100], No (%) All categories Dichotomized
CR PR (Dichot) response SD PD Indeter Not doc (Dichot) no-response
Imaging response based on RECIST (n = 100) CR 0 (0.0) 2 (2.0) NA 1 (1.0) 0 0 0 NA Agreement, % (95% CI): 52 (41.8-62.1) Agreement, % (95% CI): 71a (61.1-79.6)
PR 1 (1.0) 17 (17.0) 8 (8.0) 0 0 0 κ statistics (95% CI): 0.29 (0.14-0.43) κ statistics (95% CI): 0.37b (0.17-0.56)
(Dichot) response NA NA 20 (20.0) NA NA NA NA 9 (9.0) NA NA
SD 1 (1.0) 15 (15.0) NA 24 (24.0) 8 (8.0) 0 1 (1.0) NA Unconfirmed agreement, % (95% CI): 58 (47.7-67.8) Unconfirmed agreement, % (95% CI): 74 (64.3-82.3)
PD 0 4 (4.0) 5 (5.0) 11 (11.0) 0 0
NE 0 0 0 2 (2.0) 0 0 κ statistics (95% CI): 0.37 (0.22-0.52) κ statistics (95% CI): 0.50 (0.33-0.67)
(Dichot) no-response NA NA 20 (20.0) NA NA NA NA 51 (51.0) NA NA

Abbreviations: CAR, clinician-assessed response; CR, complete response; NA, not applicable; NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease.

a

In the analysis based on dichotomous disease control outcome (ever achieved SD or better vs not achieving at least SD), agreement was 82% (95% CI, 73.1%-89.0%) and κ statistics, 0.48 (95% CI, 0.25-0.70).

b

Analyses based on confirmed response, except when noted (N = 100).